{"id":"NCT00756548","sponsor":"Braintree Laboratories","briefTitle":"BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy","officialTitle":"BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-08","primaryCompletion":"2008-11","completion":null,"firstPosted":"2008-09-22","resultsPosted":"2013-12-27","lastUpdate":"2013-12-27"},"enrollment":386,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Colon Cancer"],"interventions":[{"type":"DRUG","name":"BLI850","otherNames":[]},{"type":"DRUG","name":"polyethylene glycol 3350 based bowel preparation","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.","primaryOutcome":{"measure":"Efficacy - Preparation Quality Using a 4 Point Scale","timeFrame":"2 days","effectByArm":[{"arm":"BLI850","deltaMin":94,"sd":null},{"arm":"Polyethylene Glycol 3350 Based Bowel Preparation","deltaMin":94,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":12,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":186},"commonTop":["Overall discomfort","Abdominal distension","Nausea","Abdominal pain","Vomiting"]}}